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3 Médecins Sans Frontières, Magburaka, Sierra Leone, 4 Manson Unit, Médecins Sans Frontières, London,
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Abstract
Between August-December 2014, Ebola Virus Disease (EVD) patients from Tonkolili District
were referred for care to two Médecins Sans Frontières (MSF) Ebola Management Centres
(EMCs) outside the district (distant EMCs). In December 2014, MSF opened an EMC in
Tonkolili District (district EMC). We examined the effect of opening a district-based EMC on
time to admission and number of suspect cases dead on arrival (DOA), and identified factors
associated with fatality in EVD patients, residents in Tonkolili District. Residents of Tonkolili
district who presented between 12 September 2014 and 23 February 2015 to the district
EMC and the two distant EMCs were identified from EMC line-lists. EVD cases were con-
firmed by a positive Ebola PCR test. We calculated time to admission since the onset of
symptoms, case-fatality and adjusted Risk Ratios (aRR) using Binomial regression. Of 249
confirmed Ebola cases, 206 (83%) were admitted to the distant EMCs and 43 (17%) to the
district EMC. Of them 110 (45%) have died. Confirmed cases dead on arrival (n = 10) were
observed only in the distant EMCs. The median time from symptom onset to admission was
6 days (IQR 4,8) in distant EMCs and 3 days (IQR 2,7) in the district EMC (p<0.001). Cases
were 2.0 (95%CI 1.4–2.9) times more likely to have delayed admission (>3 days after symp-
tom onset) in the distant compared with the district EMC, but were less likely (aRR = 0.8;
95%CI 0.6–1.0) to have a high viral load (cycle threshold22). A fatal outcome was associ-
ated with a high viral load (aRR 2.6; 95%CI 1.8–3.6) and vomiting at first presentation (aRR
1.4; 95%CI 1.0–2.0). The opening of a district EMC was associated with earlier admission of
cases to appropriate care facilities, an essential component of reducing EVD transmission.
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Frontiéres (MSF) research data are available under
the MSF data sharing agreement. Because of
ethical restrictions, individual-level data cannot be
shared publicly. The data are available under the
terms of MSF’s data sharing policy, found at http://
fieldresearch.msf.org/msf/handle/10144/306501.
Requests to access data can be made to: data.
sharing@msf.org. According to MSF data sharing
policy, December 2013, (outlined in an article in
PLOS Medicine, http://journals.plos.org/
High viral load and vomiting at admission predicted fatality. Healthcare providers should
consider the location of EMCs to ensure equitable access during Ebola outbreaks.
Introduction
On August 8, 2014 the World Health Organization (WHO) declared the Ebola epidemic in
West Africa as a Public Health Emergency of International Concern, urging states with intense
Ebola Virus Disease (EVD) transmission to ensure that “treatment centres and reliable diag-
nostic laboratories are situated as closely as possible to areas of transmission” [1, 2]. By that
time, in Sierra Leone there were more than 900 confirmed cases and 380 deaths attributed to
EVD [3]. In addition to the lack of infection prevention control (IPC) measures in existing
healthcare facilities [4, 5], the existence of few and distant Ebola healthcare facilities and a
shortage of ambulances [6, 7] contributed to limited access on quality care.
The first suspected case of EVD was identified in Tonkolili district, Sierra Leone, in late
July 2014. The district general hospital in Magburaka town (capital of Tonkolili and largest
town in the district) functioned as a holding centre for testing of suspected Ebola patients.
Prior to their transportation to an Ebola Management Centre (EMC), many patients were
admitted to either i) the district holding centres or ii) the district community care centres
(CCC—basic health care isolation units where suspected and probable cases of EVD were
treated awaiting their test results) [8]. Between July and December 2014, the lack of a local
EMC in Tonkolili district obliged all Ebola patients to be transported to EMCs in other dis-
tricts. The closest functional EMCs to Tonkolili district in that period were the Médecins Sans
Frontières (MSF) EMCs in Kailahun and in Bo (269 and 100 km from Magburaka town, re-
spectively). Patients testing positive for EVD in Tonkolili, as well as suspected cases who had
not had a confirmatory blood test, were referred to one of these two facilities depending on
bed availability. From August 2014, the MSF EMC in Kailahun started receiving an increasing
number of ambulances transferring suspected Ebola patients from Tonkolili district. After
opening in late September 2014, a similar trend was observed at the Bo MSF EMC from mid
November 2014. Interviews conducted with patients who were transferred from Tonkolili dis-
trict revealed appalling road and travel conditions, long journey times and delays in transfer
to Kailahun and Bo EMCs (personal communication GC). Holding centres were described as
crowded (some patients reported sharing the same bed with another patient) and had few staff,
resulting in long hours before dead bodies were removed. Patients reported spending a mini-
mum of one day and a maximum of 14 days in those centres. Referrals depended on the severity
of illness. Patients expressed concerns about the long distance, bad roads, crowded ambulances
(6–11 patients), lack of food and water during travel, and lack of bodily fluid disposal (for
vomit, diarrhoea). Deaths during transport were also reported (personal communication GC).
The increasing number of patients from Tonkolili in MSFs distant EMCs and the lack of
other organisations ready to open an EMC in Tonkolili, led MSF to respond in the district.
Thus, inDecember 2014, a new MSF EMC was opened 2 km from the centre of Magburaka
town and became the primary referral health facility for Ebola suspected cases in the area. At
that time, Tonkolili was one of the six districts with the highest cumulative EVD incidence
rates [9].
Early isolation of EVD suspect patients is considered a central pillar for successful outbreak
control [10–12], but there is little documentation relating EMC proximity with case fatality
and timeliness of admission.
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In this study, we aimed to determine whether accessibility of EMC facilities was associated
with timeliness of admission and case fatality.
Methods
We carried out a retrospective cohort study among residents of Tonkolili district who were
confirmed EVD cases referred to or admitted in the MSF EMCs in Kailahun, Bo and Magbur-
aka towns of Sierra Leone.
Definitions
Cases were residents of Tonkolili district who presented to the MSF EMCs between 12 Septem-
ber 2014 and 23 February 2015 and were confirmed as having EVD by positive Ebola polymer-
ase chain reaction (PCR) test of blood or saliva. This included patients who were dead on
arrival (DOA) at these facilities and tested positive posthumously. Quantitative reverse tran-
scription PCR results of cycle threshold (Ct) are a measure inversely related to Ebola viral load.
Previous analyses indicated high fatality in patients with Ct values ranging from 20.5 to 21.4
[13]. Thus, we considered the viral load high when Ct value was22 [14–16].
Time to admission was defined as the number of days between self-reported symptom
onset and admission to the EMC. We defined wet symptoms as vomiting and/or diarrhoea,
and dry symptoms as all other symptoms (e.g. headache, fatigue etc.). “Distant” EMCs were
those located in Kailahun and Bo, while “district” EMC was the EMC in Magburaka. Transport
time was the estimated hours travelling required to reach the EMC from the village of resi-
dence of the patient and was based on time records established by the MSF team based in
Magburaka.
Laboratory investigation
Specimens from Bo EMC were sent for EVD confirmation to the onsite laboratory provided
by the US Centers for Disease Control and Prevention (CDC), while those from Kailahun and
Magburaka EMCs were sent to onsite laboratories provided by the Public Health Agency of
Canada (PHAC). CDC and PHAC laboratories used quantitative PCR assays which differed
on targeting genes: CDC assays targeted Ebola virus nucleoprotein (NP) and viral protein
(VP) 40 [17] while PHAC assays targeted Ebola virus polymerase (L) and NP. [18]. In both lab-
oratories, the specimens were considered positive if the Ct values were40 [15].
Data collection and analysis
Doctors and nurses triaged patients arriving at the MSF EMCs using the standard EVD case
definition, and admitted to the EMC for confirmation those meeting the suspected case crite-
ria. Triage information was collected using the CDC standardised case investigation form in
use routinely in Sierra Leone during the outbreak. This included information on demograph-
ics, village and district of origin, onset of symptoms, clinical information (presence and type of
symptoms), and risk factors (contact with sick people, attending funerals, previous hospital or
holding centre admission, travel history). Admission data were entered by an epidemiologist
in a specifically designed linelist in Microsoft Excel. For patients previously tested, those labo-
ratory results were also recorded. Additional information was recorded during admission
including laboratory test results and final patient outcome. DOA patients were not admitted to
the EMC, so their details were recorded in a separate list including laboratory test results, and
as much information as was available on age, sex and district of origin; most other variables
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were unknown for those patients. Cases alive and DOA coming from Tonkolili District were
identified from the line-lists and the DOA list, respectively, of each MSF-operated EMC.
We described the cohort of all the cases, including the DOA cases. We measured EMC spe-
cific case-fatality as the number of deaths in EVD positive cases, out of the total number of con-
firmed EVD cases admitted to the EMCs. To examine associations between fatality, viral load,
time to admission and the variables of age, gender, chiefdom of residence, EVD symptoms,
transport time, distance in kilometres, and EMC of admission, we considered statistical signifi-
cance at P value 0.05 level and calculated crude and adjusted Risk Ratios (aRRs) for fatality
and delayed admission (>3 days after symptom onset) using binomial regression, and 95% con-
fidence intervals (95%CI). We constructed initial regression models including all variables for
which (i) the p-value (for the RR) was less than 0.20, or (ii) the RR was more than 1.1 or less
than 0.9 in the univariate analysis (corresponding to a 10% change in risk). To simplify the
models, we removed variables one at a time depending on the significance testing (p<0.05) by
the likelihood ratio (LR) test. We used linear regression to examine associations with normally
distributed continuous variables. To identify factors associated with time to admission (not nor-
mally distributed), we used generalized linear models assuming a gamma distribution and a log-
arithmic link. We analysed data using Stata (version 12, Stata Corporation, Texas, USA).
Ethical issues
The study used data collected for clinical purposes during the emergency outbreak response,
and anonymised prior to analysis. The study was conducted as part of the post-outbreak evalu-
ation and met the criteria of the MSF Ethics Review Board for exemption from ethics review
for retrospective analyses of routinely collected programmatic data [19].
Results
Overall, 372 residents of Tonkolili presented to the three MSF EMCs: 210 (56%) to Kailahun,
118 (32%) to Magburaka and 44 (12%) to Bo. Of those, 360 were admitted and 12 were dead
on arrival (DOA). Of those admitted, 187 (52%) were female; the median age was 29 years
(IQR 18, 39); 40 (11%) were children up to 5 years of age, of which 33 (83%) were referred to
distant EMCs. Admitted patients came from all 11 chiefdoms of Tonkolili, with 47% (n = 160)
coming from Kholifa Rowala, the second most populated chiefdom in the district.
Of all admitted patients, 249 (69%) were confirmed by PCR as EVD cases; 139 (56%) were
female; the median age was 28 years (IQR 17–38). The descriptive and regression analyses
focused on the 249 confirmed admitted EVD cases. Of all confirmed EVD cases, 166 (67%)
were admitted to Kailahun EMC from 12 September to 30 November 2014, 40 (16%) were
admitted to Bo EMC from 4 November to 21 December 2014, and 43 (17%) to Magburaka
EMC from 15 December 2014 to 21 March 2015 (Table 1). Thus, of all patients who presented
to EMCs, including those DOA, 83% (174/210) were confirmed EVD cases in Kailahun, 95%
(42/44) in Bo, and 36% (43/118) in Magburaka.
Malaise (90% n = 178), fever (83% n = 134), diarrhoea (63% n = 125), headache (73%
n = 140) and vomiting (60% n = 119), were the most frequent symptoms of cases reported at
admission. Of all confirmed cases, 80% presented with wet symptoms, with or without dry
symptoms; 69% in Magburaka EMC, 71% in Bo, and 84% in Kailahun.
Dead on arrival
Of 12 patients who were dead on arrival, 10 (83%) were later confirmed as cases: 8 in Kailahun
and 2 in Bo. Two DOA patients had no record of being tested: one in Kailahun and one in
Magburaka. Of all DOA cases, 50% were male.
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Time to admission
The estimated median transport time from cases’ residences to the EMCs was 4 hours (IQR
2,5 hours), significantly less for the district EMC (1 hour) compared to the distant EMCs (5
hours) (p<0.001) (Table 2). Of all the cases with transport time 2 hours (n = 42), 93% had
been admitted in the district EMC (Table 1).
The median time from symptom onset to admission was 6 days (IQR 4,8) in distant EMCs
compared with 3 days (IQR 2,7) in the district EMC (p<0.001) (Table 2). The mean age of
cases with time to admission 3 days (25.1 ± 15.5; n = 57) was lower, but not significantly
(p = 0.08), compared with that of cases with longer (>3 days) time to admission (29.1 ±14.9,
n = 162).
Cases with time to admission >3 days after symptom onset were 2.0 (95% CI 1.4–2.9) times
more likely to be admitted to the distant EMCs (81%), compared with the district EMC (41%)
(Table 1, Table 3). Findings were similar when a 2-day cut-off value for time to admission was
used or when time to admission was treated as a continuous outcome variable (data not
shown).





















Age group (years†) 5 25 (10) 5 (13) 18 (11) 2 (5) 23 (11) 0.46
6–18 51 (21) 5 (13) 35 (21) 11 (26) 40 (20)
19–45 142 (57) 23 (58) 93 (56) 26 (60) 116 (57)
46–79 30 (12) 7 (18) 19 (12) 4 (9) 26 (13)
Sex Female 139 (56) 19 (48) 99 (60) 21 (49) 118 (57) 0.31
Diarrhoea Yes 125 (63) 12 (52) 91 (69) 22 (53) 103 (66) 0.09
Vomiting Yes 119 (60) 11 (48) 88 (66) 20 (49) 99 (63) 0.09
Wet symptoms Yes 159 (80) 17 (71) 113 (84) 29 (69) 130 (82) 0.06
Transport time 2hours 42 (20) 3 (7) 0 (0) 39 (93) 3 (7) <0.001
Time to admission >3 days 163 (74) 32 (84) 115 (80) 16 (41) 147 (81) <0.001
PCR Cycle threshold 22 58 (24) 10 (30) 37 (22) 11 (26) 47 (24) 0.08
* Compares district vs distant EMCs.
† One case in Kailahun EMC did not have an age recorded.
†† column percentages; denominators change due to missing values.
https://doi.org/10.1371/journal.pone.0176692.t001













Age (years) 28 (17,38) 26 (19,41) 29 (17,37) 30 (15,40) 27 (17,37) 0.56
Time to admission (days) 6 (3,8) 7 (4,8) 6 (4,8) 3 (2,7) 6 (4,8) <0.001
Transport time (hours) 4 (2,5) 3 (3,3) 5 (4,5) 1 (1,2) 5 (3,5) <0.001
PCR Cycle threshold 26 (20,32) 26 (21,29) 28 (22,32) 24 (19,32) 27 (16,38) 0.03
*compares district EMC (Magburaka) vs distant EMCs (Kailahun and Bo).
**IQR = interquartile range.
https://doi.org/10.1371/journal.pone.0176692.t002
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Viral load and time to admission
Among all cases, the median Ct value was 26 (range 14–38) (Table 2). The median Ct value of
cases presenting to the district EMC (24; range 14–30) was significantly (p = 0.03) lower com-
pared to those presenting to the distant EMCs (27; range 16–38). The Ct value increased by
0.29 (95% CI 0.12–0.45; p = 0.018) per day increase in the time to admission, after adjusting
for age and bleeding at admission (final linear regression model). Similarly, the mean Ct value
(25.0 ± 5.3; n = 56) of cases with time to admission3 days after symptom onset was signifi-
cantly lower compared to that of cases with longer time to admission (27.3 ± 5.5; n = 156;
p = 0.0085). Cases with time to admission >3 days were less likely to have a high viral load (Ct
22) (aRR 0.8; 95% 0.6–1.0 compared to Ct>22) (Table 3).
Factors associated with fatality
Of the admitted cases, 110 (44%) died in the three EMCs: 70 (42%) in Kailahun, 20 (47%) in
Magburaka and 20 (50%) in Bo (Table 4). Case fatality was highest in those 5 years of age
(68%). On unadjusted analysis, case fatality was 2.4 (95%CI 1.7–3.4) and 1.5 (95%CI 1.1–2.2)
times higher among those with time to admission 1 day or 1–3 days, respectively, compared
with those with longer (4 days) time to admission (Table 4).
Bo and Magburaka EMCs admitted higher proportion of cases with Ct value22 (30% and
26%, respectively), compared with Kailahun (22%) (Table 1). High viral load (Ct22) at
admission (aRR = 2.6, 95%CI 1.8–3.6) and presenting with vomiting (aRR = 1.4, 95%CI 1.0–
2.0) were the two factors significantly associated with a fatal outcome in the final binomial
regression model (Table 4).
Discussion
The study provides evidence that the opening of the district EMC in Tonkolili, Sierra Leone,
was associated with reduced DOA and admission delays, with time to admission significantly
lower for cases admitted in the district EMC compared with distant EMCs. Other studies also
refer to the potential spread of the virus from patients before they were admitted to an EMC
[20, 21, 22]. Patients originating from distant districts may have contributed to Ebola virus
Table 3. Time to admission (>3 days) to Ebola Virus Disease (EMC) by selected characteristics, Tonkolili, Sierra Leone, 2014–2015, (final binomial
regression model).
Characteristics Category Patients with time to admission
(>3 days)
Adjusted Risk Ratio (aRR) 95% CI
n Total (%)
Age (years) 5 11 17 65 Ref
6–18 30 47 64 1.1 0.7–1.7
19–79 121 155 78 1.3 0.9–2.0
EMC Magburaka* 16 39 41 Ref
Kailahun 115 144 80 2.0 1.4–2.9
Bo 32 38 84 2.1 1.4–3.1
Distant EMCs* 147 181 81 2.0 1.4–2.9
PCR Cycle threshold 22 31 50 62 0.8 0.6–1.0
>22 125 162 77 Ref
*Distant EMCs = Kailahun and Bo; District EMC = Magburaka.
https://doi.org/10.1371/journal.pone.0176692.t003
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transmission locally due to the longer time spent home before seeking care and the need to tra-
verse communities to reach a distant EMC [7, 16].
Case fatality did not differ significantly between district and distant EMCs. However, those
admitted to the district EMC had higher viral load (lower Ct) at the time of admission com-
pared with those admitted to the distant EMCs. High viral load has been used to indicate
severe disease [23]. In this study, high viral load was identified as a significant risk factor for
death. Other studies found a sharp increase in case fatality from 21% in patients with low viral
load to 81% in those with high viral load [24, 25]. Our study did not include undetected cases
and deaths in the community or holding centres who did not present to an MSF EMC. It is
therefore possible that patients in the community with severe EVD symptoms did not manage
to reach a distant EMC as they may have died quickly, introducing a survival bias [2, 7, 16].
Our study indicated that viral load decreased with increasing time to admission. This is
consistent with another study that observed a rapid decline of viremia in those still alive after
the first week since onset of symptoms [23]. In our cohort, cases admitted to the distant EMCs
had longer time to admission. Patients reported spending several days in holding or CCC
before being referred. Thus, viremia may have declined by the time of admission to the distant
EMCs.
The high fatality in those reaching the EMCs within the first days of symptom onset could
also be explained by the high-level viremia among patients with early admission. Early admis-
sions were more likely in the district EMC. This suggests that, although early admission might
play a critical role to interrupt community transmission, it might not contribute to substan-
tially reduced fatality in patients presenting with high levels of viremia. However, other
authors documented the double benefit of increasing survival and interruption of transmission
once rapid response occurred at community level, ensuring timely detection of cases [26].
In our study, the proportion of positive patients admitted differed across the three EMCs,
possibly due to different admission criteria of those EMCs. Bo EMC accepted almost entirely
patients already confirmed positive. Kailahun EMC opened early in the outbreak and accepted
any suspected case. However, patients reported that only those with the most severe symptoms
were referred to Kailahun from Tonkolili. This is reflected in the high proportion of confirmed
Table 4. Case fatality, (N = 110) according to selected characteristics, Tonkolili, Sierra Leone, 2014–2015.
Characteristics Category Deaths Cases Case-fatality (%) Risk Ratio (RR) 95% CI Adjusted RR (aRR) 95% CI
Age (years) 5 17 25 68 1.7 1.2–2.4 - -
6–18 20 51 39 1.0 0.7–1.5 - -
19–45 56 142 39 Ref – - -
46–79 16 30 53 1.4 0.9–2.0 - -
Sex Male 54 106 51 Ref - - -
Female 56 138 39 1.3 1.0–1.7 - -
EMC Magburaka 20 43 47 Ref - - -
Bo 20 40 50 1.1 0.7–1.7 - -
Kailahun 70 166 42 0.9 0.6–1.3 - -
Time to admission (days) 4–21 56 165 34 Ref - -
1–3 24 46 52 1.5 1.1–2.2 - -
 1 9 11 82 2.4 1.7–3.4 - -
Vomiting No 26 79 33 Ref - -
Yes 50 119 42 1.3 0.9–1.8 1.4 1.0–2.0
PCR Cycle threshold >22 63 185 34 Ref - - -
22 47 58 81 2.4 1.9–3.1 2.6 1.8–3.6
https://doi.org/10.1371/journal.pone.0176692.t004
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cases. Magburaka EMC accepted any suspected case, in a period when more EMCs were avail-
able in other districts and community awareness may have been better, thus the triage was
more sensitive compared to the distant EMCs.
Increased transport and bed capacity in the district EMC, allowing safe isolation of cases,
made dedicated care accessible to the district population; this may have reduced infectious
time in the community for cases residing in Tonkolili.
The vast majority of the cases with transport time 2 hours had been admitted in the dis-
trict EMC. The EMC in Magburaka, located closer to the district population, admitted patients
soon after their onset of symptoms, suggesting that patients sought care early when care was
available within a short travel time. Patients reported that travel to distant EMCs involved lack
of food, water, and the ability to safely dispose of human fluid (personal communication GC).
This could have contributed to 12 patients being dead on arrival following long arduous jour-
neys, with this outcome only occurring for confirmed cases travelling to distant EMCs.
Long transfers had other negative consequences. Patients with suspected EVD were trans-
ported for long distances in ambulances, sometimes up to 11 patients per ambulance. Some of
those transferred were found to be EVD negative after testing on arrival at the EMC [12]. The
exposure such patients may have had from sharing an ambulance with EVD positive, usually
symptomatic patients, may have resulted in Ebola transmission during transfers [16]. Many
patients also reported not having been informed of their final destination or about their pros-
pects of receiving adequate care (personal communication GC). In addition, families were
only informed many months later of their relatives’ final outcomes. Similar experiences were
reported in Liberia, where families referred to EMCs as “black holes” where sick family mem-
bers disappeared [27].
The EMC in Tonkolili district was constructed by MSF within 18 days from the time the
decision was made to open an EMC in the district [28]. However, due to delays in making the
decision to open an EMC in this site, less than one fifth of Tonkolili’s known Ebola case bur-
den was admitted to the district EMC. The impact of the district EMC on the control of the
epidemic in the region might have been greater if it had been available in October 2014, when
cases from the district peaked, or in July 2014 when the first cases appeared in Tonkolili dis-
trict. By serving as the primary referral point to receive suspected EVD cases, the Tonkolili
EMC, an EMC with standard Ebola IPC procedures, may have reduced ambulance and noso-
comial transmission by reducing journey time, and removed the need for referrals to distant
EMCs. Additionally, its proximity facilitated communication with the families of the admitted
or DOA patients, which was more difficult to achieve in distant EMCs.
In our study, we observed a significant association between increased fatality and both high
viral load and vomiting at admission, which is consistent with other studies [7, 13–16]. In
addition, many patients referred to the distant EMCs had first been admitted to a holding cen-
tre or a CCC, often for a few days [8].
Limitations
The case numbers and case fatality rate represent only those patients who arrived at one of the
three MSF EMCs, thus excluding undetected cases and deaths in the community or holding
centres.
In the analysis, we have not adjusted for calendar time; patients arrived in each one of the
EMCs in different calendar times, as the district EMC opened months after the distant EMCs.
So, results might have been influenced by other, unaccounted factors.
Some dates of symptom onset may not have been accurately recorded, due to the severe
condition of patients at admission, which in some cases allowed very little clinical history to be
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obtained. However, if patient condition stabilised during admission, clinical staff re-inter-
viewed those patients to elicit more accurate information.
Being in a complex emergency context, we could only record minimal information on the
DOA patients. Those patients arrived by ambulance unaccompanied without any relative pres-
ent. Therefore, we could not collect information on time to admission and clinical characteris-
tics that would help us examine further the association between DOA and proximity to EMC.
As this study utilised only minimal data routinely collected as part of EMC management,
we could not measure several factors that may be associated with fatality, such as level of care
and comorbidities. In addition, we could not account for other changes in the response to the
Ebola outbreak, including community attitudes and behaviours, which may have influenced
the speed of identification of suspected Ebola cases.
Other factors apart from EMC proximity, may have contributed to reduced time to admis-
sion. Studies have documented that improvements in surveillance, more effective contact trac-
ing and availability of ambulances might play a role in reducing delays in accessing care [29].
However, we did not have information on these factors for all EMCs in which patients were
referred. Therefore, we could not adjust for these factors in analysis. But program reports from
agencies involved in the response suggest that the best serviced in terms of these factors were
also the districts with closer EMCs.
Conclusions and recommendations
The availability of a central district EMC was associated with reduced DOA and delays of
admission to care of EVD patients during the Ebola outbreak in Tonkolili district, Sierra
Leone in 2014–15. Potential benefits of this are likely to have been reduced community and
ambulance and nosocomial transmission, along with more standardised healthcare provision.
In any future Ebola outbreak with established transmission in the community, health authori-
ties should consider strategic location of EMCs as an important component of a successful
response strategy, taking into consideration availability of adequate health staffing, logistics,
essential medicines and medical supplies.
Acknowledgments
We would like to thank all MSF staff that were deployed to control the Ebola epidemic and
especially those working in the EMCs. We thank Sarah Venis (MSF UK) for editing assistance.
Author Contributions
Conceptualization: GT GC JG KL.
Data curation: GT GC KD JG.
Formal analysis: GT GC KD JG.
Funding acquisition: GC.
Investigation: GT AH.
Methodology: GT GC KD HD JG.
Project administration: GC JG.
Resources: GT GC KK WT MS ST AJ AH JD KL IG RB RK.
Software: GT GC KD JG.
Ebola management centre access and outcomes of Ebola Virus Disease (EVD) patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0176692 May 1, 2017 9 / 11
Supervision: GC KD.
Validation: GT GC KD KL ST MS AJ.
Visualization: GT GC KD JG.
Writing – original draft: GT.
Writing – review & editing: GT GC KD JG HD JA.
References
1. WHO Statement on the Meeting of the International Health Regulations Emergency Committee Regard-
ing the 2014 Ebola Outbreak in West Africa. 08 August 2014. Available from: http://who.int/
mediacentre/news/statements/2014/ebola-20140808/en/. Accessed 28 September 2015
2. WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, et al. West
African Ebola Epidemic after One Year Slowing but Not Yet under Control N Engl J Med. 2015 Feb 5;
372(6)
3. WHO. Ebola Response Roadmap Situation Report 1. 2014. 29 August 2014. Avialable from: http://apps.
who.int/iris/bitstream/10665/131974/1/roadmapsitrep1_eng.pdf?ua=1. Accessed 10 September 2015
4. MMWR C. Update: Ebola Virus Disease Epidemic—West Africa 2014. 19 December 2014. Available
from: http://www.cdc.gov/mmwr/pdf/wk/mm6350.pdf. Accessed 12 September 2015
5. Centers for Disease Control and Prevention. Interim Recommendations for Ambulance Service Provid-
ers in West African Areas with Ebola Outbreaks. January 14, 2015.
6. WHO. Ebola Response Roadmap Situation Report 2, 5 September 2014. Available from: http://www.
who.int/csr/disease/ebola/situation-reports/5-september-2014-en.pdf. Accessed 08 September 2015
7. Dallatomasina S, Crestani R, Sylvester Squire J, Declerk H, Caleo GM, Wolz A, et al. Ebola outbreak in
rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health. 2015 Apr; 20
(4):448–54. https://doi.org/10.1111/tmi.12454 PMID: 25565430
8. Olu O, Cormican M, Kamara KB, Butt W. Community Care Centre (CCC) as adjunct in the management
of Ebola Virus Disease (EVD) cases during outbreaks: experience from Sierra Leone. The Pan African
Medical Journal 2015; 22(Suppl 1):14.
9. Pathmanathan I, O’Connor KA, Adams ML, Rao CY, Kilmarx PH, Park BJ, et al. Rapid Assessment of
Ebola Infection Prevention and Control Needs—Six Districts, Sierra Leone, October 2014. December
12. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6349a7.htm?s_cid=mm6349a7_
w. Accessed 10 September 2015
10. Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic
Republic of the Congo: discovery and control measures. J Infect Dis. 1999 Feb; 179 Suppl 1.
11. Frieden TR, Damon I, Bell BP, Kenyon T, Nichol S. Ebola 2014—new challenges, new global response
and responsibility. N Engl J Med. 2014 Sep 25; 371(13):1177–80. https://doi.org/10.1056/
NEJMp1409903 PMID: 25140858
12. Wolz A. Face to face with Ebola—an emergency care center in Sierra Leone. N Engl J Med. 2014 Sep
18; 371(12):1081–3. https://doi.org/10.1056/NEJMp1410179 PMID: 25162580
13. Crowe SJ, Maenner MJ, Kuah S, Erickson B, Coffee M, Knust B, et al. Prognostic Indicators for Ebola
Patient Survival. Emerg Infect Dis. 2016; 22(2):217–223. https://doi.org/10.3201/eid2202.151250
PMID: 26812579
14. Yan T, Mu J, Qin E, Wang Y, Liu L, Wu D, et al. Clinical characteristics of 154 patients suspected of hav-
ing Ebola virus disease in the Ebola holding center ofJui Government Hospital in Sierra Leone during
the 2014 Ebola outbreak. Eur J Clin Microbiol Infect Dis. 2015 Oct; 34(10):2089–95. https://doi.org/10.
1007/s10096-015-2457-z PMID: 26223324
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